Sanova Flector EP plaster

Sanofi

$43.50

Flector EP plaster is suitable for external treatment of painful musculoskeletal disorders. The active ingredient diclofenac-epolamine is well absorbed through the skin and reaches the affected tissues directly, where it unfolds its analgesic, anti-inflammatory and decongestant effect.

If you do not feel better or if you feel worse, contact your doctor.

field of use

For external, local treatment of

Pain caused by muscle tension (including lumbago)
Pain and swelling after blunt injuries and sports injuries (such as sprains, strains, bruises)

Contraindications

Flector EP plaster should not be used

if you are allergic to diclofenac epolamine or any of the other ingredients of this medicine (listed in section 6).
with known hypersensitivity to acetylsalicylic acid or other non-steroidal anti-inflammatory drugs.
from the beginning of the 6th month of pregnancy and on the breast of nursing mothers.
on broken skin of any kind: weeping dermatosis (skin lesions), eczema, infected injuries, burns or wounds.
in patients with an active ulcer in the digestive tract (ulcer pepticum).
in children and adolescents under 16 years of age.

interactions

If the patch is used as intended, no interactions are known to date.

Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine.

Pregnancy:
For safety reasons, Flector EP patches should not be used during the first 5 months of pregnancy, as there is insufficient experience of use in pregnant women.

Use during the last trimester of pregnancy (last 3 months) could result in developmental disorders of the circulatory system and/or renal dysfunction in the unborn child and increased bleeding in the mother and child at birth and a delay/prolongation of the birth process.
Therefore, Flector EP patch must not be used from the beginning of the 6th month of pregnancy.

Breast- feeding:
As with other non-steroidal analgesic and anti-inflammatory drugs, the active substance in Flector EP patches, diclofenac epolamine, is excreted in small amounts in breast milk. However, no effects on the infant are anticipated at therapeutic doses of Flector EP patches. Due to the lack of controlled studies in breastfeeding women, the preparation may only be used during breastfeeding if recommended by a doctor. In this case, Flector EP patches must not be used on breasts of nursing mothers or on large areas of skin or for a long period of time.

Flector EP patches contain methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216) and propylene glycol
Methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) can cause allergic reactions, including delayed reactions. Propylene Glycol may cause skin irritation.

application

Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

The recommended dose is:

Adults and adolescents from the age of 16:
1 - 2 times a day (morning or evening) place 1 plaster on the area to be treated and press firmly. The patch is self-adhesive.

Children and adolescents under 16 years of age:
There are insufficient data on efficacy and tolerability in children and adolescents under 16 years of age (see also section 2).

Elderly:
Flector EP patches should be used with caution in elderly as they are more prone to side effects (see section 2).

Patients with renal or hepatic impairment:
For use in patients with renal or hepatic impairment see section 2.

Method of application:
Flector EP patch is intended for application to the skin.

Cut open the bag along the marking and take out a patch. Peel off the clear protective film and place the patch with the sticky side on the painful area, press and let it stick to the skin. Close the bag well after each use (pressure lock).

No special precautions are required on the affected skin area before applying the patch. 4 Apply the patch to the most painful area.

The plaster may only be used on intact, unbroken skin and should not be worn when showering or bathing.

Using multiple patches at the same time is not recommended.

The patch should be used whole.

The duration of treatment should not exceed 14 days. If your symptoms worsen or do not improve, you must definitely consult a doctor.

In adolescents 16 years of age and older, the patient/parents are advised to consult a doctor if the medicine is needed for more than 7 days to treat pain or if the symptoms worsen.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Common (affects 1 to 10 users in 100):
rash, eczema, reddening of the skin (erythema), inflammation of the skin (dermatitis) (including allergic dermatitis and contact dermatitis), itching.
Administration site reactions.

Rare (affects 1 to 10 users in 10,000):
Dermatitis that causes blisters (dermatitis bullous), dry skin.

Very rare (affects less than 1 user in 10,000):
Hypersensitivity (including hives), allergic painful swelling of the skin and mucous membranes, especially in the face area (angioedema), anaphylactic-type reactions.
blistering rash.
Asthma.
photosensitivity reaction.

Not known (frequency cannot be estimated from the available data):
Headache, dizziness, abnormal sensations (tingling or numbness) in hands and feet (paraesthesia), decreased sensitivity to touch of the skin (hypaesthesia), drowsiness, excessive muscle activity (hyperkinesis), taste disturbance (dysgeusia). ).
palpitations.
shortness of breath.
Constipation, indigestion (dyspepsia), nausea, diarrhea, vomiting, dry mouth, inflammation of the stomach lining (gastritis), upper abdominal pain, bleeding in the gastrointestinal tract.
Excessive sweating (hyperhidrosis), facial swelling, burning sensation, wasting of skin tissue (skin atrophy), skin discoloration, generalized rash. malaise, feeling hot.

composition

The active substance is:
180 mg diclofenac epolamine (EP) per patch.

The other ingredients are:
gelatin, povidone, sorbitol solution 70%, white clay, titanium dioxide (E171), propylene glycol, methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), edetate sodium (.2H2O), tartaric acid, carmellose -Sodium, Sodium Polyacrylate, Dihydroxyaluminum Glycinate, 1,3-Butanediol, Polysorbate 80, Fragrance (Dalin PH), Purified Water; polyester cloth, propylene film.

Your order will be shipped within 3-4 business days